The University of California, San Francisco has announced a $50 million gift from venture capitalist Bill Bowes to establish a new biomedical research program.
The Bowes Biomedical Investigator Program will focus on transdisciplinary and unconventional approaches to advancing science and support for scholars positioned to be next-generation leaders in their fields. To that end, the program will provide $250,000 annually over five years to junior and mid-career faculty investigators whose research interests do not fall within classic disciplinary lines.
A longtime supporter of UCSF, Bowes has now committed nearly $100 million to the university. As chair of the Mission Bay Capital Campaign, Bowes, president of the William K. Bowes, Jr. Foundation, shepherded the construction of UCSF's state-of-the-science campus. He also serves on the industry advisory board of QB3, a joint program involving UCSF, UC Berkeley, and UC Santa Cruz dedicated to incubating innovative, transdisciplinary research and ensuring that discoveries are quickly brought to market. Bowes founded Amgen, the world's largest privately held multinational biopharmaceutical firm in 1980 and founded U.S. Venture Partners in 1981.
"That Bill Bowes, a world-renowned entrepreneur, is investing in UCSF as an institution and in its best and brightest young investigators is indeed an honor," said UCSF chancellor Sam Hawgood. "Bill is a cherished friend, valued member of the UCSF Foundation board of directors, and partner. His support for our young faculty is crucial as they establish their own labs and choose their paths, for national funding sources are scarce during their early, vulnerable years."